Housing and Maintenance of Non-Human Primates

***The purpose of this notice is to:

1. Change the Proposal Response Due reflected in this notice

2. Modify the anticipated award date

3. Modify the description below to reflect the programmatic need to increase the number of primates up to a maximum of 500 at any given period in the contract performance

4. Notify potential offerors that the solicitation will be immediately available for download





The National Institute of Allergy and Infectious Diseases (NIAID), Office of Acquisitions, Acquisitions Management and Operations Branch (AMOB) has a requirement to house, feed, and care for an estimated 300 nonhuman primates of the following species: Macaca mulatta; Macaca fasicularis, Macaca nemestrina; and any other combination of Old World and New World species. The number of non-human primates required to be housed and maintained by the contractor may also be increased in increments of 50 primates - up to a maximum of 500 animals total - over the course of the contract period of performance. Offerors will also be required to conduct up to 20 procedures per month for experimental groups consisting of 4 to 12 nonhuman primates for immunogenicity and viral challenge studies of various viral strains including Simian Immunodeficiency Virus (SIV); Simian- Human Immonodefiency (SHIV) strains; Human Immunodeficiency Virus (HIV); Vaccinia wild type and recombinant viruses; attenuated and wild type adenoviruses, including recombinant adenoviruses; and attenuated and wild type Influenza viruses. Procedures performed include, but are not limited to, innoculation; animal observation and monitoring; evaluation of therapies; specimen collection and performance of clinical and pathological procedures as prescribed. Offerors must be able to provide secure and adequate dedicated storage and isolation facilities including environmentally-controlled procedure and containment rooms; necessary equipment; and qualified, experienced personnel for animal care, maintenance, and procedures conducted at the ABSL-2 and/or ABSL-3 level of containment. In order to facilitate the exchange of specimen samples to and from the project office and the contractor's facility, the offeror's housing facility must be within 50 miles of the National Institutes of Health (NIH) facilities located at 9000 Rockville Pike, Bethesda, Maryland 20892. The NIAID NIH intends to award a one-year cost type contract with four (4) one-year options beginning on or about July 1, 2008. The solicitation will be immediately available for download subsequent to the posting of this notice. No hardcopies will be distributed. Any questions concerning this requirement must be submitted in writing, by e-mail to LaDonna Stewart at lstewart@niaid.nih.gov.

The purpose of this modification to modify the anticipated solicitation availability and contract award date as follows.

The NIAID NIH intends to award a one-year cost type contract with four (4) one-year options beginning on or about May 1, 2008. The solicitation will be available for download on or about February 15, 2008. Any questions concerning this requirement must be submitted in writing, by e-mail to LaDonna Stewart at lstewart@niaid.nih.gov.



All other information provided in the previous notice as indicated below remain unchanged and in effect



The National Institute of Allergy and Infectious Diseases (NIAID), Office of Acquisitions, Acquisitions Management and Operations Branch (AMOB) has a requirement to house, feed, and care for an estimated 300 nonhuman primates of the following species: Macaca mulatta; Macaca fasicularis, Macaca nemestrina; and any other combination of Old World and New World species. The number of non-human primates required to be housed and maintained by the contractor may also be increased by up to 50 primates per year - up to a maximum of 500 animals total - over the course of the contract period of performance. Offerors will also be required to conduct up to 20 procedures per month for experimental groups consisting of 4 to 12 nonhuman primates for immunogenicity and viral challenge studies of various viral strains including Simian Immunodeficiency Virus (SIV); Simian- Human Immonodefiency (SHIV) strains; Human Immunodeficiency Virus (HIV); Vaccinia wild type and recombinant viruses; attenuated and wild type adenoviruses, including recombinant adenoviruses; and attenuated and wild type Influenza viruses. Procedures performed include, but are not limited to, innoculation; animal observation and monitoring; evaluation of therapies; specimen collection and performance of clinical and pathological procedures as prescribed. Offerors must be able to provide secure and adequate dedicated storage and isolation facilities including environmentally-controlled procedure and containment rooms; necessary equipment; and qualified, experienced personnel for animal care, maintenance, and procedures conducted at the ABSL-2 and/or ABSL-3 level of containment. In order to facilitate the exchange of specimen samples to and from the project office and the contractor's facility, the offeror's housing facility must be within 50 miles of the National Institutes of Health (NIH) facilities located at 9000 Rockville Pike, Bethesda, Maryland 20892.

The National Institute of Allergy and Infectious Diseases (NIAID), Office of Acquisitions, Acquisitions Management and Operations Branch (AMOB) has a requirement to house, feed, and care for an estimated 300 nonhuman primates of the following species: Macaca mulatta; Macaca fasicularis, Macaca nemestrina; and any other combination of Old World and New World species. The number of non-human primates required to be housed and maintained by the contractor may also be increased by up to 50 primates per year - up to a maximum of 500 animals total - over the course of the contract period of performance. Offerors will also be required to conduct up to 20 procedures per month for experimental groups consisting of 4 to 12 nonhuman primates for immunogenicity and viral challenge studies of various viral strains including Simian Immunodeficiency Virus (SIV); Simian- Human Immonodefiency (SHIV) strains; Human Immunodeficiency Virus (HIV); Vaccinia wild type and recombinant viruses; attenuated and wild type adenoviruses, including recombinant adenoviruses; and attenuated and wild type Influenza viruses. Procedures performed include, but are not limited to, innoculation; animal observation and monitoring; evaluation of therapies; specimen collection and performance of clinical and pathological procedures as prescribed. Offerors must be able to provide secure and adequate dedicated storage and isolation facilities including environmentally-controlled procedure and containment rooms; necessary equipment; and qualified, experienced personnel for animal care, maintenance, and procedures conducted at the ABSL-2 and/or ABSL-3 level of containment. In order to facilitate the exchange of specimen samples to and from the project office and the contractor's facility, the offeror's housing facility must be within 50 miles of the National Institutes of Health (NIH) facilities located at 9000 Rockville Pike, Bethesda, Maryland 20892. The NIAID NIH intends to award a one-year cost type contract with four (4) one-year options beginning on or about March 1, 2008. The solicitation will be available for download on or about January 25, 2008. No hardcopies will be distributed. Any questions concerning this requirement must be submitted in writing, by e-mail to LaDonna Stewart at lstewart@niaid.nih.gov.

The National Institute of Allergy and Infectious Diseases (NIAID), Office of Acquisitions, Acquisitions Management and Operations Branch (AMOB) is currently seeking small business sources to house, feed, and care for an estimated 300 nonhuman primates of the following species: Macaca mulatta; Macaca fasicularis, Macaca nemestrina; Cercopithecus aethiops; and any other combination of Old World and New World species. Offerors will also be required to conduct up to 20 procedures per month for experimental groups consisting of 4 to 12 nonhuman primates for immunogenicity and viral challenge studies of various strains including Simian Immunodeficiency Virus (SIV); Simian- Human Immonodefiency (SHIV) strains; Human Immunodeficiency Virus (HIV); Vaccinia wild type and recombinant viruses; attenuated and wild type adenoviruses, including recombinant adenoviruses; and attenuated and wild type Influenza viruses. Offerors must be able to provide secure and adequate storage and isolation facilities including dedicated, environmentally-controlled procedure and containment rooms; necessary equipment; and qualified, experienced personnel for animal care and maintenance, and procedures conducted at the ABSL-2 and/or ABSL-3 level of containment. In order to facilitate exchange of samples, the offeror's housing facility must be within 50 miles of the National Institutes of Health (NIH) facilities located at 9000 Rockville Pike, Bethesda, Maryland 20892. The NIAID intends to award a one-year contract with four (4) one-year options beginning on or about March 1, 2008. This announcement is specifically for small businesses. No large businesses should respond to this announcement. Small businesses including veteran-owned small business, service-disabled veteran-owned small business, small disadvantaged business, and women-owned small business concerns should respond with a capability statement, in writing, by mail or e-mail to LaDonna Stewart at lstewart@niaid.nih.gov by November 27, 2006 at 11:00am EDT. (Teaming arrangements are encouraged). Capability statements must specify the offeror's business size and type, and demonstrate similar work that has been performed in the past and the dollar value of that work. Capability statements should also demonstrate the offeror's ability to fully meet the operational and facility requirements specified above, including the ability to house animals and perform procedures at up to the ABSL-3 level of containment. Offerors should also possess, and note within their capability statements, the following: current AAALAC International file number, OPRR Animal Welfare Assurance number, and USDA Class 'R' Research Registration number. This is not a request for proposals. The intention of this announcement is to survey the market for potential offerors. Questions regarding this requirement must be submitted in writing and directed to LaDonna Stewart at lstewart@niaid.nih.gov before the closing date of this announcement.